FDA Inspection
Reprise Biomedical, Inc.Reprise Biomedical, Inc. – FDA Inspection, Nov 20, 2025
Record Details
This FDA Inspection record concerns Reprise Biomedical, Inc., with an inspection on November 20, 2025, issued by the Minneapolis District Office, covering medical devices & rad health.
- Company
- Reprise Biomedical, Inc.
- Inspection Date
- November 20, 2025
- Product Type
- Medical Devices & Rad Health
View Company Profile
ID · 1b63b727-dbf3-4338-96df-963436576142
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1292234
- FDA center
- Medical Devices & Rad Health
- Project area
- Postmarket Assurance: Medical Devices
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 820.30(g)Design Validation - Risk analysis not performed/inadequate
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Reprise Biomedical, Inc.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| July 8, 2021 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
| April 2, 2019 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| September 18, 2015 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
Other documents for Reprise Biomedical, Inc.
- FDA Inspection 1146260 - 2021-07-08
- FDA Inspection 1085602 - 2019-04-02
- FDA Inspection 943066 - 2015-09-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.